The C.A.M. Report
Complementary and Alternative Medicine: Fair, Balanced, and to the Point
  • About this web log

    This blog ran from 2006 to 2016 and was intended as an objective and dispassionate source of information on the latest CAM research. Since my background is in pharmacy and allopathic medicine, I view all CAM as advancing through the development pipeline to eventually become integrated into mainstream medical practice. Some will succeed while others fail. But all are treated fairly here.

  • About the author

    John Russo, Jr., PharmD, is president of The MedCom Resource, Inc. Previously, he was senior vice president of medical communications at, a complementary and alternative medicine website.

  • Common sense considerations

    The material on this weblog is for informational purposes. It is not medical advice or counsel. Be smart, consult your health professional before using CAM.

  • Recent Posts

  • Recent Comments

    More positive data on Bifidobacterium infantis 35624 in IBS

    A previous post summarized the favorable results from a study of the probiotic, Bifidobacterium infantis 35624 in patients with irritable bowel syndrome (IBS). Medscape has a review of IBS that includes a favorable assessment of the role of Bifidobacterium infantis 35624.

    The author, Dr. Philip Schoenfeld from the University of Michigan concludes that tegaserod (Zelnorm) is the treatment of choice.

    His thoughts regarding Bifidobacterium infantis 35624.

    • Available information supports its role as complementary treatment for patients with IBS that is not responding to first-line treatment
    • The appropriate duration of treatment is not known
    • It is not known if symptoms return after treatment
    • There are no important safety issues (so far)

    9/19/06 22:26 JR

    Leave a Comment

    You must be logged in to post a comment.